The Medicines Company Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Employees
-
60
- Latest Deal Type
-
M&A
- Financing Rounds
-
9
- Investments
-
10
The Medicines Company General Information
Description
The Medicines Company is a pharmaceutical firm that provides products to the U.S. hospital market. The company's primary commercial product, Angiomax, is an anticoagulant drug used in conjunction with aspirin for patients undergoing angioplasty. Medicines recently commercialized a new drug, Cleviprex, which is designed to control blood pressure in intensive-care settings.
Contact Information
Website
www.themedicinescompany.comCorporate Office
- 8 Sylvan Way
- Parsippany, NJ 07054
- United States
Corporate Office
- 8 Sylvan Way
- Parsippany, NJ 07054
- United States
The Medicines Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
The Medicines Company Comparisons
Industry
Financing
Details
The Medicines Company Competitors (65)
One of The Medicines Company’s 65 competitors is Synlogic, a Formerly VC-backed company based in Winchester, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Synlogic | Formerly VC-backed | Winchester, MA | ||||
| Zealand Pharma | Formerly VC-backed | Soborg, Denmark | ||||
| Apeptico | Formerly VC-backed | Vienna, Austria | ||||
| Bicycle Therapeutics | Formerly VC-backed | Cambridge, United Kingdom | ||||
| Aclaris Therapeutics | Formerly VC-backed | Wayne, PA |
The Medicines Company Patents
The Medicines Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2022109948-A | Methods for preventing cardiovascular events by reducing proprotein convertase subtilisin kexin 9 (pcsk9) protein | Active | 18-Oct-2016 | ||
| US-20180104360-A1 | Methods for preventing cardiovascular events through proprotein convertase subtilisin kexin 9 (pcsk9) protein reduction | Inactive | 18-Oct-2016 | ||
| WO-2018075658-A1 | Methods for preventing cardiovascular events through proprotein convertase subtilisin kexin 9 (pcsk9) protein reduction | Inactive | 18-Oct-2016 | ||
| US-20170239323-A1 | Oritavancin formulations | Inactive | 18-Feb-2016 | ||
| WO-2017143169-A1 | Oritavancin formulations | Inactive | 18-Feb-2016 | A61K38/14 |
The Medicines Company Signals
The Medicines Company Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
The Medicines Company Investments & Acquisitions (10)
The Medicines Company’s most recent deal was a Merger/Acquisition with Medennium. The deal was made on 01-Sep-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Medennium | 01-Sep-2019 | Merger/Acquisition | Accessories | ||
| Annovation BioPharma | 04-Feb-2015 | Merger/Acquisition | Pharmaceuticals | ||
| Tenaxis Medical | 01-May-2014 | Merger/Acquisition | Other Devices and Supplies | ||
| Annovation BioPharma | 17-Apr-2014 | Later Stage VC | Pharmaceuticals | ||
| Rempex Pharmaceuticals | 04-Dec-2013 | Merger/Acquisition | Drug Discovery |
The Medicines Company Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Targanta Therapeutics Corporation | Parsippany, NJ | 2009 | |
| Medennium | Irvine, CA | 1998 |
The Medicines Company FAQs
-
When was The Medicines Company founded?
The Medicines Company was founded in 1996.
-
Where is The Medicines Company headquartered?
The Medicines Company is headquartered in Parsippany, NJ.
-
What is the size of The Medicines Company?
The Medicines Company has 60 total employees.
-
What industry is The Medicines Company in?
The Medicines Company’s primary industry is Biotechnology.
-
Is The Medicines Company a private or public company?
The Medicines Company is a Private company.
-
What is the current valuation of The Medicines Company?
The current valuation of The Medicines Company is .
-
What is The Medicines Company’s current revenue?
The current revenue for The Medicines Company is .
-
How much funding has The Medicines Company raised over time?
The Medicines Company has raised $224M.
-
Who are The Medicines Company’s investors?
Alta Partners, BB Biotech, Dean Witter Reynolds, Eshelman Ventures, and Foresite Capital are 5 of 16 investors who have invested in The Medicines Company.
-
Who are The Medicines Company’s competitors?
Synlogic, Zealand Pharma, Apeptico, Bicycle Therapeutics, and Aclaris Therapeutics are some of the 65 competitors of The Medicines Company.
-
When was The Medicines Company acquired?
The Medicines Company was acquired on 06-Jan-2020.
-
Who acquired The Medicines Company?
The Medicines Company was acquired by Novartis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process